These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34423721)

  • 21. Association between nonalcoholic fatty liver disease and extrahepatic cancers: a systematic review and meta-analysis.
    Liu SS; Ma XF; Zhao J; Du SX; Zhang J; Dong MZ; Xin YN
    Lipids Health Dis; 2020 May; 19(1):118. PubMed ID: 32475354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opisthorchis felineus infection and cholangiocarcinoma in the Russian Federation: A review of medical statistics.
    Fedorova OS; Kovshirina YV; Kovshirina AE; Fedotova MM; Deev IA; Petrovskiy FI; Filimonov AV; Dmitrieva AI; Kudyakov LA; Saltykova IV; Odermatt P; Ogorodova LM
    Parasitol Int; 2017 Aug; 66(4):365-371. PubMed ID: 27474689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Cholangiocarcinoma Risk and its Related Factors in Wetland Geographical Communities of Ubon Ratchathani, Thailand.
    Songserm N; Woradet S; Bureelerd O; Charoenbut P
    Asian Pac J Cancer Prev; 2016; 17(4):1811-5. PubMed ID: 27221857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholangiocarcinoma: lessons from Thailand.
    Sripa B; Pairojkul C
    Curr Opin Gastroenterol; 2008 May; 24(3):349-56. PubMed ID: 18408464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiological aspects of biliary tree tumors in a region of northern Italy: emerging trends and sex-based differences.
    Floreani A; Lisiero M; Baldovin T; Baldo V
    Eur J Gastroenterol Hepatol; 2013 Nov; 25(11):1347-51. PubMed ID: 24081106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spatial analysis of hepatobiliary abnormalities in a population at high-risk of cholangiocarcinoma in Thailand.
    Thinkhamrop K; Suwannatrai AT; Chamadol N; Khuntikeo N; Thinkhamrop B; Sarakarn P; Gray DJ; Wangdi K; Clements ACA; Kelly M
    Sci Rep; 2020 Oct; 10(1):16855. PubMed ID: 33033306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Viral hepatitis B and C infections increase the risks of intrahepatic and extrahepatic cholangiocarcinoma: Evidence from a systematic review and meta-analysis.
    Tan JH; Zhou WY; Zhou L; Cao RC; Zhang GW
    Turk J Gastroenterol; 2020 Mar; 31(3):246-256. PubMed ID: 32343237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between non-alcoholic fatty liver disease and the risk of biliary tract cancers: A South Korean nationwide cohort study.
    Park JH; Hong JY; Kwon M; Lee J; Han K; Han IW; Kang W; Park JK
    Eur J Cancer; 2021 Jun; 150():73-82. PubMed ID: 33892409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholangiocarcinoma Among Children and Adolescents: A Review of the Literature and Surveillance, Epidemiology, and End Results Program Database Analysis.
    Newsome JR; Venkatramani R; Heczey A; Danysh HE; Fishman DS; Miloh T
    J Pediatr Gastroenterol Nutr; 2018 Jan; 66(1):e12-e18. PubMed ID: 28937543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for gallbladder cancer and cholangiocarcinoma: similarities, differences and updates.
    Rustagi T; Dasanu CA
    J Gastrointest Cancer; 2012 Jun; 43(2):137-47. PubMed ID: 21597894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors, epidemiology and prognosis of cholangiocarcinoma in Finland.
    Barner-Rasmussen N; Pukkala E; Hadkhale K; Färkkilä M
    United European Gastroenterol J; 2021 Dec; 9(10):1128-1135. PubMed ID: 34533900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholangiocarcinoma: risk factors and clinical presentation.
    Gatto M; Alvaro D
    Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):363-7. PubMed ID: 20496549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholangiocarcinoma.
    Sarcognato S; Sacchi D; Fassan M; Fabris L; Cadamuro M; Zanus G; Cataldo I; Capelli P; Baciorri F; Cacciatore M; Guido M
    Pathologica; 2021 Jun; 113(3):158-169. PubMed ID: 34294934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholangiocarcinoma.
    Brindley PJ; Bachini M; Ilyas SI; Khan SA; Loukas A; Sirica AE; Teh BT; Wongkham S; Gores GJ
    Nat Rev Dis Primers; 2021 Sep; 7(1):65. PubMed ID: 34504109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Endoscopic Sphincterotomy or Papillary Balloon Dilatation and Biliary Cancer: A Population-Based Cohort Study.
    Peng YC; Lin CL; Hsu WY; Chow WK; Lee SW; Yeh HZ; Chang CS; Kao CH
    Medicine (Baltimore); 2015 Jun; 94(23):e926. PubMed ID: 26061315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholangiocarcinoma--current treatment options.
    Friman S
    Scand J Surg; 2011; 100(1):30-4. PubMed ID: 21491796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonalcoholic fatty liver disease is associated with intrahepatic cholangiocarcinoma and not with extrahepatic form: definitive evidence from meta-analysis and trial sequential analysis.
    Corrao S; Natoli G; Argano C
    Eur J Gastroenterol Hepatol; 2021 Jan; 33(1):62-68. PubMed ID: 32091438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suspected cases of cholangiocarcinoma seen in reference hospitals in Lao People's Democratic Republic.
    Ayé Soukhathammavong P; Vonghachack Y; Hatz C; Akkhavong K; Odermatt P
    Parasitol Int; 2017 Aug; 66(4):510-514. PubMed ID: 27965165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for cholangiocarcinoma.
    Ben-Menachem T
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):615-7. PubMed ID: 17625428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for cholangiocarcinoma in high-risk area of Thailand: role of lifestyle, diet and methylenetetrahydrofolate reductase polymorphisms.
    Songserm N; Promthet S; Sithithaworn P; Pientong C; Ekalaksananan T; Chopjitt P; Parkin DM
    Cancer Epidemiol; 2012 Apr; 36(2):e89-94. PubMed ID: 22189445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.